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Interferon-
 
 
 
 (IFN
 
 
 
) is important in regulating the adaptive immune response, and most 
current evidence suggests that it exerts a negative (proapoptotic) effect on CD8
 
 
 
 
T cell responses. We have developed a novel technique of dual adoptive transfer, which 
allowed us to precisely compare, in normal mice, the in vivo antiviral responses of two T cell 
populations that differ only in their expression of the IFN
 
 
 
 receptor. We use this technique 
to show that, contrary to expectations, IFN
 
 
 
 strongly stimulates the development of CD8
 
 
 
 
T cell responses during an acute viral infection. The stimulatory effect is abrogated in T cells 
lacking the IFN
 
 
 
 receptor, indicating that the cytokine acts directly upon CD8
 
 
 
 T cells to 
increase their abundance during acute viral infection.
 
IFN
 
 
 
 is produced by effector CD8
 
 
 
 T cells,
Th1 CD4
 
 
 
 T cells, NK, and NK T cells.
Its receptor, which is expressed on many
cell types, is a heterodimer of IFN
 
 
 
R1 and
IFN
 
 
 
R2, both of which are required for IFN
 
 
 
signaling (1). IFN
 
 
 
 is essential for the control
of many microbial infections, acting very early
to reduce the infectious burden; mutations in
either the cytokine or its receptor lead to re-
current bacterial or parasitic infections in humans
(2). The important role of IFN
 
 
 
 in immune
defense is further highlighted by the fact that
several viruses encode proteins designed to in-
terfere with IFN
 
 
 
R signaling (3, 4). IFN
 
 
 
 also
modulates the adaptive immune response. It has
several indirect effects on CD8
 
 
 
 T cell activity:
for example, IFN
 
 
 
 induces expression of the
immunoproteasome, the TAP transporter pro-
teins and MHC class I molecules, thus rendering
intracellular pathogens more visible to the CD8
wing of the adaptive immune response. These
indirect effects of IFN
 
 
 
 should generally en-
hance CD8
 
 
 
 T cell activity but, conversely, its
direct effects on T cells are thought to be neg-
ative (suppressive). T cells treated with IFN
 
 
 
show reduced proliferation and/or increased
apoptosis (5, 6), and mice lacking IFN
 
 
 
 generate
greater numbers of 
 
Listeria
 
-specific CD8
 
 
 
 T cells
than do wild-type mice (7); IFN
 
 
 
 also is
thought to eliminate 
 
Mycobacterium
 
-specific CD4
T cells by inducing apoptosis (8). IFN
 
 
 
 favors
Th1 cell differentiation of CD4 T cells, and in-
hibits Th2 cell differentiation, apparently through
down-regulation of the IFN
 
 
 
R on Th1 cells,
which protects them from the suppressive effects
of IFN
 
 
 
; whereas Th2 cells continue to express
the receptor, and are suppressed by the cytokine
(9, 10). Therefore, current understanding holds
that the direct effects of IFN
 
 
 
 on T cells are
suppressive, and possibly proapoptotic.
Our laboratory has recently reported that
IFN
 
 
 
 produced by CD8
 
 
 
 T cells plays a key
role in establishing the differences in abun-
dance between dominant and subdominant
CD8
 
 
 
 T cell populations (i.e., IFN
 
 
 
 is required
for immunodominance; 11). Furthermore, we
have found that the rapidity of IFN
 
 
 
 expression
by CD8
 
 
 
 T cells correlates with their ultimate
abundance; fast-expressing cells become more
numerous than slow expressers (12). These
data could be explained by either positive or
negative effects of IFN
 
 
 
 (i.e., IFN
 
 
 
 could reg-
ulate the relative abundances of different T cell
populations either by actively stimulating some
cell populations, or by actively suppressing
others); and these regulatory effects on T cell
abundance could be indirect (for example, via
antigen-presenting cells) or direct. The present
study was designed to determine (a) whether
the effect of IFN
 
 
 
 on CD8
 
 
 
 T cells was stim-
ulatory or suppressive; and (b) whether the cy-
tokine acted directly on T cells, or indirectly.
 
RESULTS AND DISCUSSION
CD8
 
 
 
 T cell abundance is markedly reduced in 
the absence of IFN
 
 
 
 or IFN
 
 
 
R
 
The primary CD8
 
 
 
 T cell responses to acute
LCMV infection were compared in mice geneti-
cally deficient in either IFN
 
 
 
 (
 
 
 
 
 
/
 
 
 
) or IFN
 
 
 
R1
(
 
 
 
R
 
 
 
/
 
 
 
). After infection, the mice displayed
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strong in vivo virus-specific cytotoxicity (Fig. 1 A), consistent
with earlier in vitro reports (13, 14), and they retained the ca-
pacity to reduce viral burden by several orders of magnitude
(unpublished data). However, as judged by CD44 expression,
lower proportions of CD8
 
 
 
 T cells were activated in 
 
 
 
 
 
/
 
 
 
 and
 
 
 
R
 
 
 
/
 
 
 
 mice (Fig. 1 B), and this reduction was magnified by an
 
 
 
3-fold reduced cellularity in the spleens; as a result, mice defi-
cient in the IFN
 
 
 
 pathway had 5- to 10-fold fewer activated T
cells (Fig. 1 C). This 80–90% reduction occurs in the virus-spe-
cific population, as revealed by ICCS analyses in wild-type and
IFN
 
 
 
R
 
 
 
/
 
 
 
 mice: there was a two- to threefold lower fre-
quency of responding (IFN
 
 
 
 
 
) cells in the receptor-deficient
mice (Fig. 1 D) which, together with the reduced cellularity,
resulted in a profound reduction in antigen-specific T cell num-
bers (Fig. 1 E). These data indicate that (contrary to current
dogma) IFN
 
 
 
 strongly stimulates CD8
 
 
 
 T cell responses.
 
Expression of the IFN
 
 
 
R1 on CD8
 
 
 
 T cells varies over the 
course of viral infection
 
Next, the expression of IFN
 
 
 
R1 on CD8
 
 
 
 T cells was evalu-
ated over the course of virus infection (Fig. 2 A). 14% of
CD8
 
 
 
 T cells expressed the receptor before infection and, 8 d
after infection, 83% were 
 
 
 
R1
 
 
 
. IFN
 
 
 
R1 expression also was
up-regulated on CD8
 
 
 
 T cells after infection of IFN
 
 
 
 
 
/
 
 
 
mice (Fig. 2 B), consistent with IFN
 
 
 
-independent, TCR-
mediated, induction of the receptor, as suggested previously
(15). The kinetic analysis of 
 
 
 
R1 expression (Fig. 2
 
 
 
A) indi-
cated that there was a brief decrease in the proportion of
CD8
 
 
 
 T cells expressing 
 
 
 
R1 at 1 d after infection. The
mechanism underlying this event is unknown, but at this early
time after infection, innate immune responses are predominant
(16); however, a role for adaptive immunity cannot be ex-
cluded, because recent data have shown that naive T cells
Figure 1. CD8  T cell abundance is markedly reduced in the absence 
of IFN  or IFN R. (A) The CTL response induced in IFN  / , IFN R / , 
and control C57BL/6 mice 8 d after infection was measured in vivo by in-
jecting GP33-coated CFSEhi and uncoated CFSElo target cells into mice. The 
numbers indicate the percentage of peptide-coated cells deleted in the 
recipient mice. (B) Dot plots show CD44 expression by splenocytes at 8 d 
after infection. An uninfected C57BL/6 mouse is shown for comparison. 
(C) Bar graphs depict the number of activated cells that are CD44hi, CD62Llo, 
or Ly6A/Ehi in infected mice. (D) The virus-specific responses in wild-type 
and IFN R  mice were quantified at day 8 after infection by ICCS. GP33–41-
specific cells are identified by ovals, and the numbers indicate the percentage 
of specific cells among all CD8  T cells. (E) The numbers of epitope-specific 
CD8  T cells, based on the spleen cell count and intracellular staining, are 
shown, along with the fold reductions between  /  and  R1 /  mice. The 
bars represent the average   SD from five or six mice per group, from four 
independent experiments. For each group, the p-value compared with  /  
mice is  0.001 (unpaired Student’s t test).JEM VOL. 201, April 4, 2005 1055
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elaborate IFN  within hours of first encountering cognate an-
tigen (17). This transient down-regulation of  R1 is followed
by progressively increased expression from days 3 to 8 of infec-
tion; and, as shown in Fig. 2 C, both the number of CD8  T
cells expressing the receptor ( ), and their level of expression
(MFI;  ), increase as the infection proceeds. Elevated  R1
expression was associated with activated, CD44hi cells (Fig. 2
D). Similar changes in  R1 expression were seen in other pe-
ripheral tissues (Fig. 2 E), indicating that the changes observed
in the spleen probably represent cell-intrinsic alterations of ex-
pression, rather than changes in migratory patterns (for exam-
ple,  R1  cells entering and  R1  cells exiting the spleen).
IFN  exerts its effect directly on CD8  T cells
The observation that IFN R levels on CD8  T cells change
over the course of infection (Fig. 2) is consistent with the hy-
pothesis that IFN  acts directly on CD8  T cells to modulate
their abundance. The diminished abundance of CD8  T cells
in IFN R  mice (Fig. 1) also is consistent with this hypothe-
sis; however, since none of the cells in these knockout mice
express the receptor, it remains possible that the effect of
IFN  on T cells is indirect. Furthermore, the interpretation of
T cell data after infection of IFN  or IFN R mice is difficult,
because these mice show altered clearance of virus, and the in-
creased viral burden and/or antigen load might alter the T cell
response. To determine whether the effects of IFN  on
CD8  T cells are direct, and to circumvent the issues relating
to virus/antigen load, we have developed a novel dual adop-
tive transfer model. Spleen cells from wild-type mice con-
genic for the Ly5a marker (Thy1.2, Ly5a) were mixed with
spleen cells from  R /  (Thy1.2, Ly5b) mice, so that the
number of CD8  T cells in each group was equal. The cells
were transferred into unirradiated, wild-type mice (Thy1.1,
Ly5b) that were infected 1–2 d later. These recipient mice are
fully immunocompetent, and eradicate the virus infection
with normal kinetics. 8 d after infection, the responding
CD8  donor cells (all Thy1.2) can be readily identified (Fig. 3
A). Among these donor CD8  T cells, wild-type cells (Ly5a )
responded more vigorously to infection than IFN R1 / 
cells (Ly5b ), indicating that IFN  directly stimulates CD8 
T cells, leading to their increased abundance (Fig. 3 B). The
activation status of wild-type and IFN R /  donor popula-
tions was similar, as indicated by increased expression of
CD44 (Fig. 3 C), and both populations made IFN  in re-
Figure 2. Expression of the IFN R on CD8  T cells varies over the 
course of viral infection. (A) Representative dot plots show changes in 
expression of IFN R1 on T cells after infection. The percentages of CD8  
T cells expressing elevated amounts of the receptor are shown. (B) IFN  /  
CD8  T cells express normal amounts of IFN R1 before infection (unshaded 
histogram), and up-regulate expression 8 d after infection (shaded histo-
gram). Dotted line shows an isotype control antibody. (C) Changes over 
time in the geometric mean fluorescence of IFN R1 on wild-type splenic 
CD8  T cells ( ) and the number of IFN R1  cells per spleen ( ). (D) Resting 
(CD44lo) and activated (CD44hi) CD8  T cells are identified by a dot plot 
(left) and expression of IFN R1 among these cells is shown by the histo-
grams (right). Dotted line shows an isotype control antibody. (E) IFN R1 
expression on CD8  T cells in the indicated tissues of uninfected mice (un-
shaded) or of day 8 mice (shaded). The dotted histogram shows the decreased 
expression in spleen at one day after infection; in the other tissues, the 
change in fluorescence at this time was minimal.IFN  DIRECTLY ENHANCES CD8  T CELL RESPONSES | Whitmire et al. 1056
sponse to ex-vivo antigen stimulation (Fig. 3 D). The in-
creased abundance of IFN R  CD8  T cells in response to
infection was not due to differences in “take” immediately af-
ter adoptive transfer, because the relative proportion of cells
transferred to the same mice was approximately equal imme-
diately before infection (Fig. 3 E). Furthermore, these changes
were due specifically to infection (and not preferential rejec-
tion of  R /  cells) because mice given these cells but not in-
fected showed no change in the proportion of wild-type to
 R /  donor cells at day 0 and 8 d later (Fig. 3 F). In this ex-
perimental model, both populations of donor cells are exposed
to the same environment, so the differences in abundance are
not due to differences in APC activation, IL-2 production,
lymphoid architecture, or antigen load; we conclude that
IFN  acts directly on CD8  T cells, thereby up-regulating
the primary CD8  T cell response to infection. As noted
above, previous analyses using IFN  /  mice indicated that
the immunodominance hierarchy is influenced by IFN . To
address whether IFN  signaling affected the abundance of
CD8  T cells specific for a variety of epitopes, epitope-spe-
cific responses were measured in these mice (Fig. 3 G). As was
seen for GP33–41 (presented by H-2Db), differences of two- to
sixfold also were observed for CD8  T cells specific to NP396–
404 (H-2Db), GP276–286 (H-2Db), and NP205–212 (H-2Kb) indi-
cating that both dominant and subdominant responses, and re-
sponses restricted to different MHC molecules, are increased
when the T cells express IFN R1. To investigate whether
IFN  signaling in CD8  T cells was autocrine in nature, a
second dual adoptive transfer was performed, this time mixing
Thy1.2,Ly5b IFN  /  cells (which express IFN R) and
Figure 3. The stimulatory effect of IFN  on CD8  T cells requires 
that they express IFN R. Equivalent numbers of wild-type (Thy1.2 , 
Ly5a ) and IFN R /  (Thy1.2 , Ly5a ) CD8  T cells were mixed and adop-
tively transferred intravenously into unirradiated, Thy1.1 mice. The recipient 
mice were infected and the responses of the donor (Thy1.2 ) cells were 
measured 8 d after infection. (A) Representative dot plot shows the ex-
panded donor cell populations (Thy1.2 ), and these cells were gated, and 
are analyzed in B–G. (B) IFN R  CD8  T cells outnumber their IFN R  
counterparts by  4:1. (C) CD44 expression on donor cells; the percentage 
of cells within each quadrant is shown. (D) The antigen-specific response 
of the donor cells was measured by ICCS. The numbers represent the re-
sponding donor cells as percentage of all donor cells. (E) The proportion of 
wild-type and IFN R1  donor CD8  T cells in these same mice at day 0 
(measured in the blood before infection) is shown. (F) The percentage of 
donor cells that are Ly5a  or Ly5a  in an uninfected recipient mouse at 
day 0 (measured in blood) and 8 d later (measured in spleen). (G) The ratio 
of  /  to  R /  donor cells is shown for four epitopes, based on ICCS. Each 
point represents an individual animal, and the means   SD are shown
as horizontal lines. For each of four epitopes, the responses in  /  and
 /  cell populations were compared using unpaired Student’s t test. The
p-values are: 0.0039 (GP33); 0.0001 (NP396); 0.021 (GP276); and 0.038 
(NP205).JEM VOL. 201, April 4, 2005 1057
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Thy1.2,Ly5a wild-type cells. IFN  /  CD8  T cells ex-
panded to the same extent as the cotransferred wild-type cells
(unpublished data), indicating that autocrine production of
IFN  is not required for normal CD8  T cell responses.
The stimulatory actions of IFN  on CD8  T cells occur 
during the course of virus infection
The reduced response of IFN R  T cells to LCMV infec-
tion, shown above, most likely reflects the lack of IFN  sig-
naling during infection. Nevertheless, other explanations are
conceivable; e.g., although equivalent numbers of IFN R 
and IFN R  CD8  T cells were cotransferred into recipient
mice, it is formally possible that the frequency of LCMV-
specific precursors within each population might have been
different. To ensure that equivalent numbers of LCMV-spe-
cific precursors were being transferred, we used TcR-trans-
genic mice. GP33–41 TcR-transgenic mice were backcrossed
either to wild-type mice expressing Ly5a (to provide a
source of TcR-transgenic IFN R , Thy1.2 , Ly5a  CD8 
T cells), or to the IFN R /  mice (as a source of TcR-
transgenic IFN R / , Thy1.2 , Ly5b  cells), and 3   104
CD8  T cells from each population were mixed (Fig. 4 A)
and adoptively transferred into a normal Thy1.1 recipient
mouse. By day 8 after infection, the Thy1.2-transgenic cells
had expanded dramatically, to 1–4   107 cells per spleen,
and were easily identifiable as a large proportion of the CD8
response (Fig. 4 B). Consistent with our findings using non-
transgenic T cells, the IFN R -transgenic T cells (Ly5a )
responded better than the IFN R / -transgenic cells in the
same host (Fig. 4 C). Tetramer staining reflected the numer-
ical difference between IFN R /  and IFN R /  cells (Fig.
4 D). At 8 d after infection, all of the transferred cells, re-
gardless of their IFN R status, showed a highly activated
phenotype; they were CD44hi, and showed down-regulation
of CD62L and IL-7R  (Fig. 4, E–G) as well as increased ex-
pression of CD43 (1B11) and IL-2R  (CD122; unpublished
Figure 4. The stimulatory actions of IFN  on CD8  T cells occur during 
the course of virus infection. TcR-transgenic mice were bred as described 
in the text, to provide a source of IFN R1  TcR-transgenic CD8  T cells 
(Thy1.2 , Ly5a ), and IFN R1 /  TcR-transgenic CD8  T cells (Thy1.2 , 
Ly5a ). (A) Equal numbers of these IFN R1  (shaded)- and IFN R1 /  
(unshaded)-transgenic CD8  T cells were mixed and are shown (dotted 
line   isotype control). This 1:1 mix of IFN R1  and IFN R1  cells was in-
jected into Thy1.1 recipients (each host mouse received a total of 6   104 
TcR-transgenic CD8  T cells), and the following day the recipient mice 
were infected. 8 d later, the responses of the two donor cell populations 
were analyzed by flow cytometry. (B) The expanded Thy1.2 TcR-transgenic 
donor cells are enclosed in an oval, and only these cells are analyzed in 
C–J. (C) There are threefold more IFN R  (Ly5a ) cells than IFN R  cells. 
(D) The higher number of IFN R1  cells is confirmed by Db33-41 tetramer 
staining. (E–G) The activation status of the day 8 donor cells is similar, 
regardless of their expression of IFN R. The cells are CD44hi, and at day 8, 
both donor populations show similar reductions in CD62L and CD127. 
(H) A similar proportion of each donor cell population produces IFN  upon 
GP33 peptide stimulation. (I) The ratio of  /  to IFN R / -transgenic donor 
cells is summarized from 12 mice analyzed from three independent exper-
iments (left); 11 of the 12 animals showed a ratio  1 (dotted line). The 
numbers of IFN R1  and  R / -transgenic cells were calculated from 12 
mice (right). The averages   SD are indicated. The differences between
the two groups was statistically significant, as indicated by a p-value of 
0.0025, derived from a two-tailed paired Student’s t test. (J) The antiapop-
tosis marker bcl-2 is reduced at day 8, to the same extent in the IFN R  
and the IFN R  populations.IFN  DIRECTLY ENHANCES CD8  T CELL RESPONSES | Whitmire et al. 1058
data). The similarities in phenotypic markers were paralleled
by equivalent antigen responsiveness: 85% of IFN R  cells,
and 82% of IFN R  cells, produced IFN  in response to
GP33 peptide (Fig. 4 H). Thus, the presence or absence of
the IFN R has little effect on CD8  T cell activation or an-
tigen-responsiveness, but it has a considerable effect on T cell
abundance. The latter is summarized by results from 12 indi-
vidual recipient mice (Fig. 4 I); IFN R  cells almost always
outnumbered their IFN R /  counterparts. The abundance
of CD8  T cells is determined by the balance between cell
proliferation and cell death. The latter is thought to be medi-
ated largely by apoptosis, and we considered the possibility
that IFN  might increase the levels of antiapoptotic proteins
in CD8  T cells. Therefore, we evaluated the expression of
the antiapoptotic protein bcl-2, and found it to be similar in
IFN R  and IFN R  CD8  T cells (Fig. 4 J); the reduction
observed at day 8 in wild-type cells is consistent with pub-
lished data (18), and also occurs in IFN R  cells.
In summary, we show here that IFN  acts directly on
CD8  T cells, thereby increasing their abundance. Although
the mechanism underlying the increase in T cell numbers re-
mains to be determined, it is known that very early events
can have a profound effect on the effector and memory
phases of CD8  T cell responses (19–21), and recent data in-
dicate that IFN  and its receptor play a key role in directing
the very earliest stages of naive CD4  cell commitment (22).
Our data provide a possible explanation for the observations
that (a) IFN  modulates the immunodominance hierarchy
of CD8  T cell responses (7, 11), and (b) the rapid onset of
IFN  production by a CD8  T cell may determine the ulti-
mate abundance of its progeny (i.e., its immunodominance;
12). We propose that, early in the immune response, IFN 
produced by a CD8  T cell can act directly upon the cell it-
self, or upon neighboring CD8  T cells, enhancing their ul-
timate abundance. Consistent with this possibility, gene chip
analyses of antigen-specific CD8  T cells from the acute
phase of the response show induction of a number of IFN -
activated genes (23). The conclusion that IFN  serves as a
growth factor/costimulatory molecule for T cell responses is
at odds with previous studies showing that IFN  suppresses
T cell responses. Increased T cell responses occur in IFN  / 
mice given rLM(ActA ) or Mycobacterium (7, 8), but this
could reflect delayed pathogen clearance, resulting in a
greater antigen load that stimulates continued T cell prolifer-
ation. Others have shown that CD8  T cells in LCMV-
infected IFN R  mice are hyperproliferative; although in that
model, there is a delay in virus clearance that may modify
the T cell response (24). Can our findings be integrated with
current dogma? The biological effects of several cytokines
differ depending on the time at which they are expressed.
For example, IL-2 can either enhance T cell responses or in-
hibit them, depending on when it is administered during vi-
rus infection (25, 26), and IFN /  can enhance T cell re-
sponses (27) but also can induce T cell apoptosis (28).
Perhaps the effect of IFN  on CD8  T cells also changes
over the course of an ongoing immune response, as sug-
gested by studies of transformed human T cells (29); its early
effects may be stimulatory (as shown here), and its later ef-
fects suppressive. Our demonstration that IFN  may stimu-
late, rather than abrogate, T cell responses may provide an
explanation for the deleterious effects of this cytokine when
used to treat multiple sclerosis (30), and counsels caution for
its future use in autoimmune diseases, and in other circum-
stances in which immunostimulation might be harmful.
MATERIALS AND METHODS
Mice and virus.  C57BL/6 mice were purchased from The Scripps Re-
search Institute (TSRI) breeding facility. IFN  /  mice and IFN R1 / 
mice (both strains backcrossed 10 generations to C57BL/6), and C57BL/6
mice congenic for Thy1.1 were purchased from Jackson ImmunoResearch
Laboratory. C57BL/6.Ly5a mice were provided by Dr. Charlie Surh
(TSRI). P14 TCR-transgenic mice specific for the LCMV epitope GP33–41
were crossed to C57BL/6.Ly5a mice to generate TcR-transgenic IFN R 
Ly5a mice; and to C57BL/6 IFN R1 /  mice to generate TcR-transgenic
IFN R  Ly5b mice. Mice were infected by intraperitoneal administration
of 2   105 plaque forming units of LCMV, Armstrong strain. All experi-
ments were approved by the TSRI Animal Care and Use Committee.
Flow cytometry.  Spleen cells were stained directly ex vivo with anti-
CD8 (clone 53–6.7), anti-Thy1.2 (CD90.2 clone 53–2.1), anti-CD44 (clone
IM7), Ly6A/E (clone D7), and anti-Ly5.1 (Ly5a, clone A20; eBioscience).
Antibodies used for staining IFN R1 (rat, clone GR20) and the correspond-
ing isotype control antibodies were purchased from BD-PharMingen. The
intracellular staining (ICCS) assay was performed as described previously
(11). In vivo cytotoxicity was assayed by labeling naive B6.Ly5a splenocytes
with either 3 or 0.3 M CFSE (5,6-carboxy-fluorescein diacetate succini-
midyl ester; Molecular Probes). The CFSEhi cells were coated with the GP33
peptide, and the CFSElo cells were left uncoated. After extensive washing,
equal numbers of the CFSEhi and CFSElo cells were mixed, and transferred
into either naive recipients or day 8–infected mice. After 8 h, Ly5a  cells
were identified by flow cytometry; the percent killing was calculated as
100 {[(% peptide coated in infected/ % uncoated in infected)/(% peptide
coated in uninfected/% uncoated in uninfected)]   100}. Cell staining was
analyzed by four-color flow cytometry at the TSRI core facility using a BD
Biosciences FACSCALIBUR and Cell Quest software.
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